BB-loop ͉ protein-protein interaction ͉ IL-1␤ signaling ͉ fever
M
embers of the Toll-like receptor (TLR)͞IL-1 receptor superfamily play key roles in the activation of the innate immune system by bacterial components from Gram-negative and Gram-positive bacteria (1) (2) (3) . The monomers of the heterodimeric proinflammatory cytokine receptor, the IL-1 type I receptor (IL-1RI), and the IL-1R accessory protein (IL-1RAcP) are members of this superfamily that on ligand binding initiate intracellular signaling by dimerization and recruitment of the adapter protein MyD88 through homotypic binding of a cytosolic recognition domain [Toll͞IL-1R͞resistance (TIR) domain] between IL-1RI and MyD88 (4, 5) . MyD88 is composed of an N-terminal death domain (DD), an intermediate region (ID) , and a C-terminal TIR domain (6) . MyD88 homodimers are thought to be associated via interaction between DD and TIR-TIR domains. TIR-TIR interactions of MyD88 with the agonist occupied IL-1RI on the one hand and with the downstream interleukin receptor-associated kinase (IRAK) on the other are thought to mediate IL-1␤ signaling (7) .
MyD88 seems to play a key role in the transduction of infectious and inflammatory signals from TLR͞IL-1Rs to the activation of gene transcription via NF-B activation (2) . The expression levels of MyD88 and its differential splicing regulate important phenomena such as endotoxin tolerance (8, 9) , or IFN-␥ and granulocyte-macrophage colony-stimulating factor (GM-CSF) actions (10) . Evolution, transgenic, and molecular biological experiments point to MyD88 as a pivotal element in signal transduction from the TLR͞IL-1R family: pox viruses like vaccinia express A46R and A52R proteins that have dominant negative effects on MyD88 recruitment and block TIR-mediated signaling in the host (11) . MyD88 Ϫ/Ϫ animals lack all responses to IL-1 (12) , and show lowered resistance to Toxoplasma gondii infection (13) . Furthermore, expression of the dominant negative form of MyD88 blocked IL-1-induced NF-B activation in several cellular models (6) . However, MyD88 is not the only adapter protein that can transduce lipopolysaccharide (LPS) signals. Recently, adapter proteins such as Mal͞Tirap have been shown to mediate LPS-induced signaling cascades even in the absence of MyD88 (14, 15) .
The importance of the TIR domain-mediated homotypic interaction between TLRs and MyD88 is best demonstrated by a point mutation (P712H) in the TIR domain of TLR4 (the LPS receptor). This mutation, by preventing the recruitment of adapter proteins, renders mice carrying the P712H point mutation endotoxin resistant (16) .
The structural basis for TIR-mediated homotypic interactions was elucidated by x-ray structure of the TIR domain of human TLR2, consisting of five-stranded parallel ␤-sheets and of five surrounding ␣-helices interconnected by loops (17) . A large conserved surface, involving the BB-loop with consensus sequences (F͞Y)-(V͞L͞I)-(P͞G) in different Toll receptors and MyD88 homologs, emerges as key to the TIR domain-mediated homotypic protein-protein interaction.
We have synthesized analogs of the central 3-aa sequence of the BB-loop and studied their effect on IL-1RI signaling in vitro and in vivo. The first active compound, hydrocinnamoyl-L-valyl pyrrolidine (4a in Fig. 1 ), showed that it is possible to mimic the in vitro and in vivo effects of the dominant negative form of MyD88, or of the extracellular binding IL-1R antagonist in blocking IL-1RI-mediated signaling. The ability of this relatively small molecule to regulate protein-protein interactions is of note. These findings may also be of pharmacological importance because the blockade of IL-1 signaling has therapeutic effects in rheumatic arthritis and sepsis as shown by the recently introduced IL-1R antagonist (Kinneret) in clinical practice.
Methods
Synthesis of TIR͞BB-Loop Mimics. Synthesis of 2a. Pyrrolidine (3 ml, 36 mmol) was added to a solution of commercial BOC-L-valinehydroxysuccinimide ester (1a; 1.5 g, 4.77 mM) in toluene (15 ml). The reaction mixture was stirred at ambient temperature for 8 h. The precipitate was filtered, and the filtrate was evaporated at reduced pressure. The remaining oil was dissolved in dichlo- Synthesis of 4a. The amine triflate 3 (0.9 g, 3.4 mmol) was dissolved in dry DCM (10 ml). Triethylamine (2 ml) was added to this solution followed by hydrocinnamoyl p-nitrophenolate (1.4 g, 5.1 mmol) dissolved in DCM (5 ml). The reaction mixture was stirred at ambient temperature overnight and thereafter evaporated. The residue was dissolved in tetrahydrofuran (30 ml), and water (10 ml) and triethylamine (5 ml) were added to destroy the excess p-nitrophenyl ester. The solution was stirred for 8 h at ambient temperature and then diluted with DCM. The organic phase was washed with water until the aqueous layer was colorless. The organic layer was separated and then evaporated in vacuo. The slightly yellowish oil was dried in vacuo for 24 h. Yield 67%. Synthesis of 4b. The amine triflate 3 (0.9 g, 3.4 mmol) was dissolved in acetic anhydride (10 ml), and triethylamine (1 g) was added. The reaction mixture was stirred at ambient temperature for 8 h and evaporated in vacuo. The residue was dissolved in toluene (50 ml), and the solution was evaporated. This procedure was repeated three times to assure the removal of triethylamine and trifluoroacetic acid. The resulting oil was dried in vacuo for 96 h, and after standing it crystallized. Yield Ͼ90%. Mp 56°C. The 1D NMR spectra were recorded on a Bruker (Billerica, MA) DRX 600 (600 MHz) spectrometer by using the solvent signals as internal reference. Crystallographic data were collected on a Siemens (Iselin, NJ) SMART (18) diffractometer equipped with a charge-coupled device area detector by using graphite monochromatized MoK ␣ radiation [(MoK ␣ ) ϭ 0.71073 Å]. Data in the frames corresponding to an arbitrary hemisphere of data were integrated by using SAINT (19) . Data were corrected for Lorentz and polarization effects and were further analyzed by using XPREP. An empirical absorption correction based on the measurement of redundant and equivalent reflections and an ellipsoidal model for the absorption surface was applied by using SADABS. The structure solution and refinement were performed by using SHELXTL (refining on Cell Culture. EL4 murine thymoma cells (American Type Culture Collection no. TIB-39) were grown in DMEM supplemented with 10% FBS, 4 mM glutamine, and 2 mM Pen-Strep (GIBCO). Cells were washed in the medium above without serum, and resuspended at a cell density of 3-4 ϫ 10 6 per ml in the absence of serum, and returned to the incubator for 4 h to allow recovery.
For spleen cell isolation, spleens from 10-12 mice were aseptically removed and collected in cold PBS. Spleens were then positioned in a 100-mm Petri dish and thoroughly grinded with the flat part of a syringe in 5 ml of RPMI medium 1640, supplemented with 58 mg͞liter glutamine and 10 units͞liter penicillin. After connective tissue removal, the cell suspension was transferred on top of a 3-ml layer of Ficoll-Plaque Plus (Amersham Pharmacia Biosciences), and centrifuged at 100 ϫ g for 20 min at room temperature. Lymphocyte fraction was finally resuspended in RPMI medium 1640, and allowed to recover for 4-16 h before experiments.
Cell Exposures and Protein Extract Preparation. Murine IL-1␤ (R & D Systems) and LPS (Sigma) were dissolved in sterile double distilled water, and 4a was dissolved in DMSO. After serum deprivation, either EL4 cells or spleen cells were exposed to varying concentrations of 4a for 15 min before IL-1␤ (10 nM) exposure or LPS (10 ng͞ml) exposure. Time course experiments (0-30 min) showed that maximal mitogen-activated protein (MAP) kinase phosphorylation occurred at 15 min and 30 min for IL-1␤ and LPS incubations, respectively. These exposure times were used throughout the studies. After IL-1␤ or LPS exposure, EL4 cells or freshly isolated lymphocytes were centrifuged and washed once with ice cold PBS, and resuspended in ice cold lysis buffer (1% Nonidet P-40͞20 mM Tris⅐Cl, pH 7.5͞10 mM EGTA͞40 mM ␤-glycerolphosphate͞2.5 mM MgCl 2 ͞2 mM orthovanadate͞1 mM DTT͞1 mM PMSF͞20 g/ml aprotinin͞20 g/ml leupeptin) and processed as described (21) . Protein concentration was determined by using the bicinchoninic acid method (BCA, Pierce).
Western Blot Analysis. For the study of p38, extracellular signalregulated kinase (ERK) 1͞2, and c-Jun amino-terminal kinase (JNK) MAP kinases, 40 g of protein samples were fractionated on 8% SDS͞PAGE, and transferred to nitrocellulose membranes (Micron Separations, Westboro, MA) by using a semidry electrotransfer system (Novablot, Amersham Pharmacia). Membranes were blocked with 5% milk in TBS-T buffer (20 mM Tris, pH 7.5͞150 mM NaCl͞0.05% Tween 20), and were then incubated with phospho-specific antibodies directed to the phosphorylated forms of p38, ERK1͞2, and JNK (Cell Signaling Technology, Beverly, MA). Protein bands were visualized by chemiluminescence using SuperSignal (Pierce). For densitometric analysis and quantification, blots were subsequently reprobed with specific antibodies directed to non-phospho form of p38, ERK1͞2, and JNK (Santa Cruz Biotechnology). In parallel experiments for p38 MAP kinase phosphorylation determinations, a commercially available ELISA system was also employed (BioSource International, Camarillo, CA), using 10 g of total cell lysate. Results were calculated as absorbance per g of protein and expressed as a percentage of the basal value (in the absence of any exposure).
Immunoprecipitation and Sandwich ELISA. For coimmunoprecipitation experiments, 80 g of total cell lysate were incubated with 20 l of anti-MyD88-conjugated agarose (Santa Cruz Biotechnology) over night at 4°C, washed three times in PBS, and resuspended in Laemmli sample buffer. Proteins were separated in 10% SDS͞PAGE, and coimmunoprecipitating bands were detected by Western blot using specific antibodies (anti-IL-1RI and TLR4 from Santa Cruz). As a control, counter immunoprecipitations were also performed. For the development of the sandwich ELISA system, 96-well plates were coated overnight with anti-MyD88 antibody (2 mg͞ml in bicarbonate͞PBS buffer, pH 7.5). Plates were washed of excess antibody in PBS-Tween 20, protein extracts (10 g) were added, and incubation was allowed for 16-24 h at 4°C. Plates were again washed as above, and anti-IL-1RI (1 g͞ml) or TLR4 (1 g͞ml) was added for 2 h at room temperature. Plates were washed, and a secondary antibody conjugated to horseradish peroxidase (1:2,000, Vector Laboratories) was added and incubated at room temperature for 1 h. After washing with PBS, color was developed by using commercially available reagents (Biosource International) and read in a Bio-Rad plate reader at 450 nm. As controls, incubations were performed in the absence of each of the antibodies, one at a time, and in the absence of cell extract, which was considered the blank, and subtracted from the values obtained. Values were calculated as absorbance per g of protein, and expressed as a percentage of basal (control) conditions. Densitometric Analysis and Quantification. The intensity of immunoreactive bands obtained in autoradiographic films was measured with an imaging densitometer (Bio-Rad). Phosphoprotein levels per protein unit ratios were obtained by dividing the phospho-immunoreactive densitometry values by those obtained for the respective protein redetection blots. All values were expressed as a percentage of basal levels for each experiment. 
Results

Synthesis of TIR͞BB-Loop Mimics.
The synthesis proceeded uneventfully through use of standard coupling and deprotection techniques. Reaction of commercially available BOC-L-valine hydroxysuccinimide ester 1a ( Fig. 1) with pyrrolidine in toluene in the presence of triethylamine afforded amide 2a in Ϸ90% yield. Analogous reaction of the phenylalanine ester 1b gave compound 2b. Removal of the BOC group by trifluoroacetic acid in dichloromethane resulted in the corresponding amine 3. Acylation of 3 with p-nitrophenylhydrocinnamate in toluene afforded amide 4a as heavy oil. Acylation of 3 with acetic anhydride resulted in acetamide 4b that crystallized on drying in vacuo.
Stable crystals suitable for the single crystal x-ray analysis were obtained. Two crystallographically independent molecules are found in the asymmetric unit that forms a dimer through two hydrogen bonds between the NH groups and the valine carbonyls (Fig. 2) . No deviations from the regular bond lengths and angles were detected in the crystalline state.
Biological Effects of TIR͞BB-Loop Mimics. As a central proinflammatory mediator, IL-1 induces the expression of multiple genes involved in the inflammatory process. IL-1 binds to IL-1RI, after which the receptor forms a complex with IL-1RAcP. This result triggers the recruitment of the adaptor protein MyD88, which associates with IL-1RI through its carboxyl-terminal TIR domain. Once recruited to the IL-1R complex, MyD88 activates the interleukin receptor-associated kinases 1-4 (IRAK1 to -4), which become phosphorylated and dissociate from MyD88 and associate with the tumor necrosis factor receptor-associated factor 6 (TRAF6), leading to the activation of the MAP kinases p38, ERK1͞2, and JNK) and the activation of IB, which induces the activation of transcription factor NF-B. Similarly, LPS binding, via CD14, to TLR4 induces the recruitment of MyD88 and triggering of the same signaling cascade as IL-1␤ binding to IL-1RI (1) .
To analyze the effects of TIR͞BB-loop mimics on IL-1RI-mediated signaling, we used the activation of the MAP kinase p38, for which reliable phospho-specific antibodies and ELISA systems have been developed. Activation of p38 MAP kinase occurs through dual (Thr, Tyr) phosphorylation of the tripeptide Thr-Gly-Tyr by MAP kinase kinases 3 and 6, producing a fully active kinase (22) . Antibodies specific to the dual-phosphorylated p38-enzyme have been proven as an efficient tool to analyze the activation state of this MAP kinase on activation of a broad spectrum of membrane receptors.
In mouse thymoma EL4 cells, a 15-min preincubation with 4a (0-100 M) inhibited IL-1␤ (10 nM)-mediated phosphorylation of p38 MAP kinase, where 4a concentrations above 10 M showed statistical significance (Fig. 3) . To analyze the specificity of 4a effect in preventing IL-1RI͞MyD88 association, we performed coimmunoprecipitation and sandwich-ELISA assays by using antibodies specific for MyD88 and IL-1RI. IL-1␤ exposure of EL4 cells induced a significant increase in MyD88͞IL-1RI association when analyzed both by sandwich ELISA (Fig. 3B) and coimmunoprecipitation assays using MyD88-specific antibody followed by Western blots with IL-1RI antibody (not shown). It should be noted that the sandwich ELISA system gave more reliable results than the coimmunoprecipitation assay, probably due to the higher amount of antibody and protein extract needed to perform the immunoprecipitation and Western blot redetection. The IL-1␤-mediated association of MyD88͞IL-1RI was prevented by preincubation of EL4 cells with 4a (10-100 M; Fig. 3B ). To further prove the effects of 4a on MyD88͞IL-1RI association and prevention of IL-1␤ signaling, we performed similar experiments as those in EL4 cells in freshly isolated lymphocytes from mouse spleen. When IL-1␤ (10 nM)-mediated activation of p38 MAP kinase was analyzed in lymphocytes, 4a showed similar inhibitory effects as in EL4 cells (Fig. 4A) . When the association of MyD88͞IL-1RI in freshly isolated lymphocytes was analyzed, 4a showed inhibitory effects on the protein-protein interaction in the same concentration range as that observed for EL4 cells (Fig. 4B) .
MyD88 has been shown to participate in signaling not only by IL-1RI but also through other members of the Toll receptor superfamily (TLR1 to -10; ref. 1 ). To analyze whether the inhibitory effects of 4a were specific for IL-1␤ signaling, and thus to IL-1RI͞MyD88 interaction, or they extended to other members of the Toll receptor family, we studied the effects of 4a on LPS signaling in freshly isolated lymphocytes. LPS has been shown to bind to CD14 and TLR4, which, by recruiting MyD88, initiate signaling cascades similar to those elicited by IL-1␤ binding to IL-1RI͞IL-1RAcP, i.e., MAP kinases p38, ERK1͞2, and JNK, as well as the activation of the transcription factor NF-B. Addition of LPS (10 ng͞ml) to freshly isolated lymphocytes induced a robust activation of the three MAP kinase pathways (Fig. 4C) . However, addition of 4a (100 M) did not have any effect on the activation state of these MAP kinases. Moreover, 4a (100 M) did not affect the association of TLR4͞ MyD88 (Fig. 4D) , demonstrating the specificity of 4a for the association of IL-1RI with MyD88.
As a further proof of the effects of 4a on IL-1␤ signaling, we analyzed the TIR͞BB-loop mimic in a well-established paradigm in vivo: the IL-1␤-induced fever response. As previously demonstrated, injection of IL-1␤ (15 g͞kg) i.p. induced a fever response that peaks at Ϸ2 h postinjection, and lasts Ϸ6 h (Fig.  5) . 4a (200 mg͞kg) applied i.p. 15 min before IL-1␤ injection attenuated this fever response (Fig. 5) . Of note, the handling effect on the core body temperature, which has been shown to be independent of IL-1␤ (23), was not affected by 4a, again demonstrating the specificity of the inhibitory effects of the TIR͞BB-loop mimic 4a for IL-1␤ mediated effects.
Discussion
The TIR-TIR domain-mediated homotypic interactions play a key role in Toll receptor signaling in the innate immune system. The presence of TIR domains on Toll receptors that respond to microbial components, on the receptor for the proinflammatory cytokine IL-1, and on the cytosolic adapter protein MyD88 that mediates the signals to interleukin receptor-associated kinase kinase suggests that disruption of TIR-TIR signaling would be of therapeutic value in the treatment of infectious and inflammatory diseases.
The structural basis of homotypic TIR-TIR domain interactions in the case of human TLR2 proposed by Xu and colleagues (17) shows that a 5-aa-long BB-loop in the middle of the five ␤-strand, five ␣-helix, 110-aa-long TIR domain is key to the interaction between the large conserved surfaces. The affinity of this interaction was estimated to be low (10 Ϫ3 to 10 Ϫ5 M). We show here that a low molecular weight mimic of the three protruding amino acids in the BB-loop [(F͞Y)-(V͞L͞I)-(P͞G)] (consensus for several IL-1RI, MyD88, and Toll receptors) can successfully inhibit interactions between IL-1RI and MyD88. Whereas there is no structural evidence that the hydrocinnamoyl group assumes the role of the F in the sequence, the crystal structure of the close 4a analog (compound 4b, Fig. 2) shows a conformation typical of a ␤-strand and that of the BB-loop. Moreover, 4b forms a dimeric structure in the solid state, as might be expected of a mimic of structures involved in homotypic dimerization. The inhibition of this proteinprotein interaction upstream in the IL-1 signaling pathways blocks IL-1-mediated in vitro and in vivo responses, similarly to the dominant negative form of MyD88.
Although the lack of effect of 4a in the LPS-mediated activation of MAP kinase signaling cascades could be attributed to the activation of these cascades by other adapter proteins, as was shown for MyD88-deficient mice (14) , 4a showed no inhibitory effect on the interaction between TLR4 and MyD88. The specificity shown by the small BB-loop mimic reported here for the IL-1R͞MyD88 interaction over those of TLR4͞MyD88 suggests that the different TIR domain-mediated interactions may be amenable to inhibition by relatively low molecular weight, cell penetrating, and systemically active compounds. Further, the amino acid variations between the BB-loops in TIR domains of different TLRs hint at the possibility of specific pharmacological targeting of a given TLR signaling pathway, given the sequence variations in TIR domains of MyD88 and MyD88-like adapter proteins and those of the TIR domains of the TLRs. In a broader context, the example of 4a provides additional evidence for the regulation of protein-protein interactions through mimics of the appropriate protein surfaces created by chemical synthesis. Indeed, the past years have witnessed the start of a trend in synthesizing nonpeptidic small molecule-mimics that can inhibit protein-protein interaction or mimic one of the interacting proteins (24) . Thus, low molecular weight agonists for EPO receptor (25) and insulin receptor tyrosine kinase (26) , as well as inhibitors of chemokinechemokine receptor interaction (27) and Myc͞Max dimerization (28), were described. The present work adds another example to the list of small molecules that can specifically interfere with protein-protein interaction. 
